consider
investig
hostmicrobi
interact
patient
chronic
rhinosinus
cr
hope
elucid
mechan
diseas
better
treatment
attent
paid
bacteri
infect
potenti
underli
defect
innat
immun
bacteri
biofilm
present
patient
cr
undergo
surgic
intervent
presenc
associ
sever
diseas
wors
surgic
outcom
role
viral
fungal
infect
patient
cr
less
clear
evid
primari
defect
mucociliari
clearanc
patient
cr
decreas
level
certain
antimicrobi
protein
notabl
lactoferrin
found
sinu
secret
wherea
level
antimicrobi
protein
found
normal
primari
defect
tolllik
receptor
found
patient
cr
although
reduc
express
tolllik
receptor
report
patient
recalcitr
nasal
polyp
polymorph
bitter
tast
receptor
recent
associ
refractori
cr
persist
pseudomona
aeruginosa
infect
downregul
innat
immun
maladapt
h
tissu
inflamm
also
describ
patient
recalcitr
nasal
polyp
suggest
link
persist
infect
date
effect
mean
restor
hostmicrobi
balanc
mitig
diseas
patient
cr
remain
elus
j
allergi
clin
immunol
key
word
chronic
rhinosinus
host
microbi
biofilm
innat
immun
antimicrobi
discuss
articl
jaci
journal
club
blog
wwwjacionlineblogspotcom
hostmicrobi
interact
play
critic
role
cr
diseas
initi
perpetu
articl
aim
summar
knowledg
hostmicrobi
interact
elucid
relat
normal
sinu
physiolog
patholog
patient
chronic
rhinosinus
cr
includ
subset
regard
chronic
rhinosinus
without
nasal
polyp
crssnp
chronic
rhinosinus
nasal
polyposi
crswnp
allerg
fungal
rhinosinus
afr
studi
innat
immun
hostmicrobi
interact
patient
cr
focus
patient
refractori
recalcitr
diseas
refractori
cr
defin
basi
failur
stabil
surgeri
antibiot
salin
rins
topic
steroid
treatment
somewhat
differ
recalcitr
cr
defin
base
recurr
nasal
polyp
np
polyp
surgeri
definit
noteworthi
patient
refractori
polyposi
exampl
might
evid
infect
wherea
patient
recalcitr
polyposi
might
littl
evid
infect
evid
maladapt
h
mucos
inflamm
viral
upper
respiratori
tract
infect
potenti
highli
relev
cr
averag
healthi
adult
person
experi
common
cold
per
year
http
wwwniaidnihgovtop
commoncoldpagesoverviewaspx
healthi
subject
onset
time
cours
cold
symptom
level
viral
mrna
detect
nasal
secret
day
map
experiment
rhinoviru
infect
patient
asthma
chronic
obstruct
pulmonari
diseas
manifest
significantli
higher
peak
rhinoviru
viral
load
durat
symptom
asthmat
patient
also
manifest
correspond
decreas
induct
type
b
type
iii
interferon
given
similar
asthma
cr
tissu
level
fact
mani
cr
exacerb
occur
viral
season
plausibl
similar
defect
exist
patient
cr
howev
experiment
rhinoviru
infect
studi
patient
cr
innat
antivir
respons
rhinoviru
infect
involv
activ
type
interferon
interferonregulatori
factor
gene
activ
increas
nitric
oxid
product
epitheli
product
human
bdefensin
hbd
rant
found
augment
product
downregul
product
rant
model
chemokin
interferoninduc
protein
also
induc
studi
incid
rhinoviru
infect
patient
cr
studi
jang
et
al
report
patient
cr
detect
rhinoviru
infect
studi
examin
nasal
lavag
fluid
turbin
epitheli
cell
collect
rhinoprob
mucos
curett
rhinoprob
arlington
scientif
arlington
tex
patient
cr
healthi
control
subject
hc
use
rtpcrbase
assay
found
lavag
fluid
patient
cr
hc
turbin
epitheli
cell
hc
neg
picornaviru
wherea
epitheli
cell
sampl
patient
cr
posit
examin
reveal
patient
cr
posit
result
posit
result
rhinoviru
unclear
whether
repres
subclin
infect
patient
studi
time
point
vitro
experi
wang
et
al
infect
np
nasal
turbin
epitheli
cell
patient
crswnp
sphenoid
sinu
turbin
epitheli
cell
hc
rhinoviru
rhinoviru
signific
differ
rate
infect
induct
found
group
found
cultur
airway
epitheli
cell
patient
crssnp
exagger
respons
stimul
combin
doublestrand
rna
tolllik
receptor
tlr
agonist
surrog
viral
infect
plu
cigarett
smoke
extract
exagger
product
rant
final
although
studi
quit
limit
lack
evid
persist
viral
infect
patient
cr
use
pcr
methodolog
wood
et
al
use
special
techniqu
optim
recoveri
anaerob
bacteria
identifi
bacteria
roughli
children
cr
prospect
studi
adult
identifi
posit
bacteri
cultur
variabl
percentag
patient
cr
review
meltzer
et
al
coagulaseneg
staphylococcu
speci
common
aerob
isol
sever
studi
often
accompani
staphylococcu
aureu
viridian
streptococci
organ
associ
acut
bacteri
rhinosinus
cultur
case
sever
studi
gramneg
enter
rod
includ
pseudomona
aeruginosa
klebsiella
pneumonia
proteu
mirabili
enterobact
speci
escherichia
coli
also
isol
organ
rare
found
middl
meatu
cultur
healthi
subject
recent
studi
intraop
sinu
cultur
simultan
analysi
cultur
biofilm
report
posit
cultur
case
predomin
aureu
p
aeruginosa
isol
frequenc
anaerob
organ
recov
adult
cr
vari
wide
anaerob
found
mainli
investig
use
special
techniqu
optim
recoveri
sever
speci
includ
pigment
prevotella
fusobacterium
bacteroid
peptostreptococcu
speci
isol
support
role
anaerob
bacteria
chronic
maxillari
sinus
finegold
et
al
found
recurr
sign
symptom
twice
frequent
cultur
yield
anaerob
bacteri
count
greater
cfuml
support
evid
came
detect
igg
antibodi
anaerob
organ
commonli
recov
sinu
aspir
name
fusobacterium
nucleatum
prevotella
intermedia
antibodi
level
organ
decreas
patient
respond
therapi
decreas
therapi
fail
recent
studi
molecular
techniqu
shed
new
light
potenti
role
anaerob
patient
cr
see
role
atyp
bacteri
infect
patient
cr
studi
convent
cultur
techniqu
molecular
techniqu
overcom
issu
detect
noncultur
bacteria
suggest
atyp
mycobacteri
infect
rare
patient
cr
sought
patient
refractori
cr
see
addit
text
articl
onlin
repositori
wwwjacionlineorg
bacteri
biofilm
patient
cr
biofilm
format
import
surviv
mechan
microorgan
attach
surfac
format
biofilm
complex
process
control
differ
genet
pathway
depend
growth
condit
exposur
membranetarget
antibiot
furthermor
biofilmassoci
bacteria
known
enhanc
resist
antimicrobi
agent
rel
float
plankton
bacteria
biofilm
format
sinonas
mucos
surfac
first
describ
later
sever
studi
multipl
techniqu
biofilm
detect
describ
discuss
addit
text
articl
onlin
repositori
tabl
articl
onlin
repositori
www
jacionlineorg
summar
result
sever
studi
biofilm
includ
fungal
biofilm
patient
cr
includ
techniqu
use
biofilm
identif
studi
subcategor
patient
crssnp
crswnp
afr
eosinophil
mucin
chronic
rhinosinus
emcr
one
studi
found
biofilm
present
patient
np
lower
preval
report
studi
cr
studi
use
scan
electron
microscopi
sem
transmiss
electron
microscopi
tem
confoc
scan
laser
microscopi
cslm
taken
total
exclud
studi
confin
patient
np
preval
biofilm
cr
case
seri
summar
tabl
presenc
biofilm
prognost
valu
presenc
bacteri
biofilm
determin
use
cslm
found
associ
sever
sinu
diseas
preoper
wors
radiolog
symptom
score
wors
sinu
symptom
nasal
endoscopi
score
month
surgeri
singleorgan
h
influenza
biofilm
associ
mild
clinic
radiograph
diseas
normal
sinu
mucosa
short
time
surgeri
contrast
polymicrobi
biofilm
biofilm
contain
aureu
associ
sever
diseas
poorer
postop
cours
presenc
bacteri
biofilm
strongli
associ
persist
mucos
inflamm
endoscop
sinu
surgeri
biofilmposit
patient
vs
biofilmneg
patient
one
studi
show
likelihood
detect
bacteria
biofilmform
capac
increas
relat
prior
endoscop
sinu
surgeri
possibl
reflect
sever
diseas
similarli
zhang
et
al
found
associ
biofilm
formingcapac
vitro
clinic
sampl
prior
sinu
surgeri
nasal
steroid
use
month
sampl
collect
associ
presenc
np
allergi
samter
triad
associ
posit
cultur
result
least
suggest
biofilm
might
greater
relev
patient
nonpolypoid
cr
summari
studi
suggest
mucos
biofilm
marker
sever
mucos
diseas
predictor
poorer
outcom
sinu
surgeri
basi
anim
model
rhinosinus
biofilm
format
might
reflect
sever
chronic
sinu
infect
intracellular
bacteria
patient
cr
intracellular
intraepitheli
staphylococcu
aureu
iesa
first
report
sinu
epithelium
corriveau
et
al
use
peptid
nucleic
acid
fluoresc
situ
hybrid
fish
assay
studi
iesa
found
epithelium
patient
cr
also
seen
hc
rais
question
patholog
signific
recent
studi
use
similar
aureu
fish
probe
propidium
iodid
counterstain
cslm
iesa
detect
patient
cr
undergo
sinu
surgeri
none
hc
simultan
analysi
reveal
presenc
aureu
biofilm
iesaposit
tissu
tissu
iesaneg
patient
cr
cslmfishpropidium
iodid
techniqu
advantag
abl
detect
iesa
aureu
biofilm
tissu
sampl
present
unclear
whether
presenc
iesa
prognost
patholog
signific
beyond
afford
presenc
biofilm
studi
link
presenc
iesa
specif
defect
epitheli
innat
immun
bacteriolog
patient
cr
use
molecular
techniqu
evolv
view
bacteri
involv
patient
cr
expand
beyond
infect
individu
pathogen
consider
increas
bacteri
burden
biofilm
format
alter
microbi
commun
ie
microbiom
microbiom
univers
cultur
noncultur
microorgan
present
specif
ecolog
nich
gastrointestin
tract
sinu
mucosa
analysi
microbiom
gain
much
recent
attent
novel
mean
studi
hostmicrobi
relat
variou
organ
includ
respiratori
tract
sinus
made
possibl
advent
broadplatform
molecular
techniqu
includ
microarray
sequenc
method
allow
identif
full
microbiom
base
microbi
rna
commonli
use
techniqu
pyrosequenc
identifi
bacteri
speci
base
conserv
eubacteri
ribosom
gene
techniqu
studi
microbi
commun
rapidli
emerg
includ
method
quantifi
bacteri
divers
represent
specif
bacteri
speci
bacteri
load
burden
stephenson
et
al
use
pyrosequenc
modifi
eubacteri
primer
amplifi
region
rrna
gene
eighteen
patient
cr
np
compar
control
subject
convent
cultur
identifi
bacteri
growth
patient
cr
percentag
posit
control
subject
mention
averag
isol
per
sampl
contrast
result
pyrosequenc
posit
mean
rang
isol
per
sampl
preval
organ
patient
cr
anaerob
bacteria
diaphorobact
peptoniphilu
speci
wherea
coagulaseneg
staphylococcu
speci
identifi
sampl
aureu
corynebacterium
propionibacterium
speci
also
identifi
control
subject
feazel
et
al
obtain
middl
meatu
swab
compar
bacteri
cultur
pyrosequenc
result
patient
cr
includ
np
versu
hc
standard
bacteriolog
cultur
posit
patient
cr
hc
averag
isol
report
per
subject
rang
isol
statist
signific
differ
found
number
isol
obtain
patient
cr
control
subject
commonli
cultur
organ
coagulaseneg
staphylococci
aureu
propionibacterium
acn
use
pyrosequenc
preval
dna
sequenc
type
detect
coagulaseneg
staphylococci
corynebacterium
speci
p
acn
aureu
gener
cultur
organ
compris
less
organ
identifi
mean
sequenc
bacteria
identifi
use
cultur
identifi
mean
pyrosequenc
case
nonspecif
cr
cultur
result
mix
gramneg
rod
associ
pyrosequenc
detect
moder
mix
anaerob
repres
total
sequenc
identifi
confirm
longheld
content
investig
studi
report
low
preval
anaerob
cr
sampl
might
methodolog
flaw
relat
sampl
collect
bacteri
cultur
studi
feazel
et
al
aureu
select
enrich
patient
cr
mean
cultur
patient
cr
vs
hc
dna
sequenc
repres
aureu
detect
similar
percentag
patient
cr
hc
greater
abund
bacteri
burden
aureu
sequenc
found
patient
cr
studi
antibiot
exposur
asthma
associ
reduc
microbi
divers
increas
aureu
abund
use
special
techniqu
mucu
preserv
sampl
collect
salinemoisten
nonstick
gauz
prevent
adsorpt
mucu
gauz
prompt
transport
sampl
laboratori
stain
ponikau
et
al
report
patient
cr
detect
fungal
hypha
mucu
obtain
diseas
sinus
virtual
patient
cr
hc
also
posit
fungal
cultur
nasal
secret
broad
array
fungi
isol
latter
find
confirm
independ
group
investig
found
posit
fungal
stain
cultur
patient
cr
hc
gosepath
et
al
analyz
tissu
specimen
patient
cr
use
highli
sensit
pcr
assay
detect
fungal
dna
patient
cr
univers
fungal
primer
primer
specif
alternaria
speci
contrast
although
univers
primer
detect
fungal
dna
hc
none
subject
posit
result
alternaria
speciesspecif
primer
fungal
biofilm
also
describ
patient
cr
heali
et
al
use
specif
bacteri
fish
dna
probe
panfung
probe
detect
biofilm
mucos
sampl
patient
emcr
afr
cr
three
mucos
sampl
control
subject
also
collect
sampl
also
analyz
use
epifluoresc
microscopi
bacteri
biofilm
demonstr
sampl
control
specimen
fungal
element
detect
associ
bacteri
biofilm
major
case
foreman
et
al
analyz
patient
cr
control
subject
simultan
presenc
bacteri
fungal
biofilm
use
bacteriaspecif
fish
probe
univers
probe
fungu
identifi
bacteri
biofilm
fungal
biofilm
patient
cr
studi
patient
compar
preval
fungal
biofilm
patient
emcr
afr
cr
epitheli
barrier
function
import
maintain
mucos
hydrat
prevent
penetr
foreign
particl
includ
microb
subepitheli
layer
defect
epitheli
barrier
function
found
key
risk
factor
develop
atop
dermat
lead
increas
transepiderm
water
loss
possibl
contribut
directli
increas
suscept
aureu
skin
infect
tight
junction
protein
essenti
normal
epitheli
barrier
function
compos
branch
network
seal
strand
strand
act
independ
key
tight
junction
protein
claudin
occludin
intestin
tight
junction
protein
effici
restrict
microb
penetr
subepitheli
tissu
acut
revers
chang
barrier
function
associ
intestin
viral
bacteri
infect
includ
rotaviru
enteropathogen
e
coli
whether
primari
defect
epitheli
barrier
function
increas
suscept
inflammatori
bowel
diseas
ibd
present
establish
primari
defect
epitheli
tight
junction
protein
describ
patient
cr
np
soyka
al
found
np
decreas
transtissu
resist
irregular
patchi
decreas
express
tight
junction
protein
occludin
zonula
occluden
effect
like
secondari
tissu
inflamm
shown
vitro
cultur
hc
np
epitheli
cell
presenc
result
downregul
occludin
zonula
occluden
express
wherea
cultur
ifng
caus
upregul
protein
unlik
tight
junction
less
known
role
adheren
junction
protein
desmosom
protein
epitheli
barrier
function
decreas
express
epitheli
adheren
junction
protein
ecadherin
describ
np
link
manifest
epithelialmesenchym
transit
decreas
express
desmosom
junction
protein
desmoglein
desmoglein
report
latter
studi
cultur
human
bronchial
epitheli
cell
tnfa
downregul
desmoglein
express
suggest
defect
desmoglein
express
np
might
secondari
underli
inflammatori
process
mucociliari
clearanc
essenti
process
normal
sinu
function
impair
mucociliari
clearanc
lead
mucostasi
bacteri
colon
biofilm
format
cr
genet
engin
mice
lack
normal
cilia
spontan
bacteri
sinus
classic
exampl
abnorm
ciliari
function
primari
ciliari
dyskinesia
pcd
also
known
immotil
cilia
syndrom
pcd
rare
usual
autosom
recess
disord
character
sinopulmonari
diseas
later
defect
eg
situ
inversu
male
infertil
pcd
tradit
diagnos
base
ultrastructur
defect
cilia
identifi
patient
pcd
involv
outer
dynein
arm
inner
dynein
arm
mutat
analys
discov
patient
pcd
carri
mutat
dynein
gene
estim
normal
ciliari
function
involv
gene
product
addit
mutat
account
remain
patient
pcd
like
uncov
recent
screen
unrel
pcd
famili
identifi
patient
famili
reduc
outer
dynein
arm
carri
mutat
gene
product
might
function
tightli
bound
axonemeassoci
protein
somewhat
similar
clinic
syndrom
known
young
syndrom
character
obstruct
azoospermia
normal
sperm
structur
function
recurr
sinopulmonari
infect
unlik
patient
pcd
mutat
ciliari
structur
gene
identifi
patient
young
syndrom
problem
presum
caus
abnorm
mucu
sever
studi
establish
cr
associ
acquir
reduct
mucociliari
clearanc
mucociliari
clearanc
typic
normal
clearanc
infect
restor
normal
sinu
drainag
confirm
vitro
studi
show
sinonas
mucos
explant
patient
cr
show
blunt
ciliari
beat
frequenc
respons
cholinerg
adrenerg
stimul
normal
respons
within
hour
cultur
lai
et
al
report
increas
express
centrosom
protein
inflam
sinu
tissu
patient
cr
known
prevent
termin
step
ciliari
matur
show
could
induc
vitro
proinflammatori
cytokin
cultur
sinu
epitheli
cell
concomit
inhibit
ciliogenesi
contrast
evid
primari
defect
mucociliari
clearanc
account
cr
date
genet
associ
studi
patient
refractori
cr
uncov
gene
polymorph
would
suggest
primari
defect
mucociliari
clearanc
composit
sinu
mucos
secret
fig
illustr
gener
structur
sinu
epithelium
submucos
mix
seromucin
gland
stroma
summar
mani
protein
peptid
produc
sinu
mucos
cell
submucos
seromucin
mix
gland
compris
seri
duct
interconnect
serou
mucou
tubul
termin
acini
alcian
blue
use
stain
acid
mucoglycoprotein
within
epitheli
goblet
cell
submucos
gland
wherea
serou
gland
stain
serou
gland
report
major
site
product
antimicrobi
peptid
although
mani
antimicrobi
peptid
illustr
produc
surfac
epitheli
cell
submucos
gland
proteaseactiv
receptor
demonstr
submucos
gland
heighten
glandular
secretori
respons
proteaseactiv
receptor
agonist
includ
hous
dust
mite
extract
describ
patient
cr
lysozym
lysozym
catalyz
breakdown
bacteri
cell
wall
peptidoglycan
cleav
b
glycosid
linkag
nacetylmuram
acid
nacetylglucosamin
http
lysozym
local
primarili
serou
cell
submucos
mix
gland
neutrophil
weak
stain
mucu
cell
submucos
mix
gland
goblet
cell
decreas
immunostain
lysozym
report
longstand
case
cr
howev
recent
studi
report
increas
rather
decreas
immunostain
patient
cr
studi
wood
et
al
increas
immunoreact
lysozym
found
mucos
biopsi
specimen
patient
crssnp
crswnp
includ
lowlevel
immunostain
epithelium
lactoferrin
similar
lysozym
lactoferrin
detect
primarili
serou
cell
submucos
gland
although
zhang
et
al
report
increas
lactoferrin
immunostain
patient
cr
psalti
et
al
report
decreas
lactoferrin
mrna
protein
level
patient
cr
even
decreas
express
presenc
bacteri
biofilm
secretori
leukocyt
proteinas
inhibitor
secretori
leukocyt
proteinas
inhibitor
slpi
protect
epitheli
tissu
serin
proteas
includ
trypsin
leukocyt
elastas
cathepsin
g
http
cation
protein
high
affin
leukocyt
elastas
also
antibacteri
immunomodulatori
properti
third
abund
antimicrobi
protein
upper
airway
antibacteri
properti
slpi
thought
resid
ntermin
domain
protein
activ
could
mediat
cation
charg
slpi
antibacteri
activ
paeruginosa
aureu
staphylococcu
epidermidi
candida
albican
role
slpi
innat
immun
control
inflamm
complex
furthermor
shown
decreas
level
slpi
found
pseudomona
speciesinfect
lung
patient
cystic
fibrosi
due
degrad
neutrophil
elastas
slpi
recov
purul
maxillari
sinu
secret
patient
maxillari
sinus
studi
link
abnorm
slpi
cr
antimicrobi
peptid
defensin
cathelicidin
protein
defensin
cathelicidin
main
famili
antimicrobi
peptid
present
airway
secret
express
airway
epithelium
repres
small
kda
cation
peptid
either
produc
constitut
induc
microbi
product
includ
tlr
ligand
cytokin
growth
factor
adefensin
produc
mainli
neutrophil
intestin
paneth
cell
wherea
primarili
produc
epitheli
cell
epitheli
cell
product
constitut
wherea
product
induc
neglig
express
found
normal
nasal
mucosa
reduc
express
found
epitheli
cell
isol
np
human
subject
cathelicidin
express
neutrophil
cathelicidin
proform
proteolyt
process
proteinas
result
releas
skin
serin
proteinas
control
cleavag
detect
epitheli
cell
submucos
gland
inflammatori
cell
nasal
tissu
explant
induc
cultur
fungal
allergen
aspergillu
alternaria
speci
clear
pattern
defici
product
sinu
tissu
demonstr
patient
cr
bactericidalpermeabilityincreas
protein
plunc
famili
protein
famili
protein
includ
bactericidalpermeabilityincreas
protein
bpi
lpsbind
protein
lbp
antimicrobi
effect
gramneg
bacteria
bind
bacteri
lp
caus
growth
arrest
inhibit
lpsinduc
activ
inflammatori
respons
although
bpi
lbp
found
airway
secret
littl
studi
level
nasal
sinu
secret
plunc
protein
member
palat
lung
nasal
epithelium
clone
plunc
famili
structur
relat
lbp
bpi
recent
studi
suggest
physiolog
relev
concentr
plunc
inhibit
p
aeruginosa
biofilm
format
vitro
without
act
directli
bactericid
find
suggest
plunc
protein
might
relev
patient
refractori
cr
found
differenti
express
serou
mucou
cell
respect
submucos
gland
uncin
tissu
decreas
level
found
np
rel
seen
healthi
control
uncin
tissu
like
reflect
decreas
number
submucos
gland
np
level
correl
decreas
lactoferrin
level
similarli
wu
et
al
found
plunc
protein
level
reduc
np
somewhat
increas
patient
cr
rel
hc
consist
studi
show
increas
number
submucos
gland
patient
crssnp
rel
hc
delet
malign
brain
tumor
gene
encod
altern
splice
protein
refer
salivari
agglutinin
sag
former
secret
bronchoalveolar
line
fluid
wherea
latter
present
saliva
molecul
ident
interact
agglutin
sever
gramneg
gramposit
bacteria
includ
streptococcu
mutan
bacterium
respons
dental
cari
interact
surfact
protein
spa
surfact
protein
spd
varieti
host
protein
involv
innat
immun
wound
heal
precis
role
human
diseas
yet
elucid
overexpress
np
mainli
submucos
gland
ficolin
collectin
spa
spd
conglutinin
mannosebind
lectin
ficolin
collectin
collagen
lectin
solubl
innat
pattern
recognit
receptor
innat
function
resembl
antibodi
adapt
immun
subunit
ficolin
collectin
recogn
carbohydr
array
microbi
target
globular
trimer
carbohydraterecognit
domain
spa
ficolin
mannosebind
lectin
mbl
also
share
structur
similar
ficolin
mbl
spa
activ
complement
whether
collectin
interact
immun
cell
receptor
unclear
studi
ficolin
upper
airway
spa
express
report
increas
sinu
mucos
biopsi
specimen
patient
crssnp
also
present
np
howev
woodworth
et
al
found
compar
express
spa
spd
hc
patient
crswnp
studi
spa
spd
immunoreact
found
epitheli
cell
submucos
seromucin
gland
one
studi
report
reduc
immunostain
spd
nasal
submucos
gland
lack
induct
spd
aspergillu
alternaria
speci
allergen
cultur
nasal
explant
patient
nonallerg
fungal
eosinophil
sinus
contrast
allergen
induc
spd
product
hc
patient
cr
ramanathan
et
al
show
cultur
human
sinonas
epitheli
cell
presenc
h
cytokin
hour
reduc
express
antimicrobi
innat
immun
gene
use
realtim
pcr
elisa
flow
cytometri
includ
spa
experi
reduc
express
innat
factor
hc
patient
cr
howev
given
mucos
spa
express
increas
patient
crswnp
signific
vitro
suppress
spa
unclear
mbl
also
refer
mannosebind
protein
calciumdepend
serum
protein
bind
carbohydr
determin
surfac
wide
rang
pathogen
virus
bacteria
fungi
protozoa
therebi
activ
complement
cascad
act
directli
opsonin
mbl
member
collectin
famili
protein
structur
similar
complement
compon
mbl
defici
associ
increas
incid
upper
respiratori
tract
infect
children
presum
adapt
immun
system
still
immatur
howev
studi
mbl
defici
defin
express
mbl
defici
allel
danish
adult
found
signific
differ
infecti
diseas
preval
mortal
mbldefici
subject
versu
control
subject
howev
pauciti
studi
mbl
level
genotyp
popul
patient
cr
one
studi
found
increas
serum
level
mbl
patient
crssnp
crswnp
complement
compon
complement
compon
serum
amyloid
protein
produc
sinonas
epitheli
cell
serum
amyloid
function
acutephas
opsonin
gramneg
bacteria
includ
e
coli
p
aeruginosa
outer
membran
protein
famili
member
differ
found
express
serum
amyloid
patient
cr
compar
seen
hc
increas
express
factor
b
mrna
found
tissu
patient
afr
crswnp
compar
seen
hc
function
signific
unclear
constitut
produc
high
level
sinu
epithelium
virtu
high
constitut
level
induc
nitric
oxid
synthas
concentr
healthi
maxillari
sinu
ppm
exce
necessari
antibacteri
effect
vitro
vastli
higher
produc
nose
lung
normal
exhal
valu
ppb
antimicrobi
effect
sinus
might
also
relat
stimul
increas
ciliari
beat
frequenc
complex
reactiv
radic
superoxid
metal
thiol
product
also
downstream
innat
signal
bitter
tast
receptor
see
recent
experi
demonstr
norespons
quorumsens
mechan
vibrio
harveyi
shewanella
oneidensi
regul
biofilm
format
bacteria
stimul
biofilm
format
control
level
bacteri
cyclic
diguanosin
monophosph
whether
similar
mechan
exist
pathogen
remain
explor
report
low
level
mmoll
stimul
biofilm
format
aureu
multipl
innat
pattern
recognit
receptor
pathway
either
known
potenti
relev
sinu
epithelium
includ
transmembran
tlr
intracellular
nucleotidebind
oligomer
domain
nod
receptor
dectin
receptor
bitter
tast
receptor
tabl
articl
onlin
repositori
wwwjacionlineorg
summar
pattern
recognit
receptor
involv
microbi
recognit
airway
epitheli
cell
microbi
ligand
abnorm
describ
patient
cr
fig
summar
salient
featur
hostmicrobi
interact
involv
trigger
innat
immun
respons
patient
cr
sinonas
epitheli
cell
express
tlr
signal
demonstr
sinonas
epitheli
cell
tlr
ligat
airway
epitheli
cell
result
activ
specif
intracellular
signal
pathway
review
bal
hiemstra
lead
product
innat
antimicrobi
peptid
cytokin
chemokin
amplifi
innat
respons
eg
neutrophil
infiltr
activ
adapt
immun
respons
receptor
greatest
divers
ligand
recogn
wide
array
gramposit
gramneg
bacteria
well
fungi
part
format
heterodim
pathway
extrem
import
host
respons
gramneg
bacteri
infect
airway
polymorph
associ
gramneg
bacteri
infect
patient
intens
care
unit
respons
human
tracheobronchi
epithelium
lp
requir
coreceptor
studi
tlr
signal
pathway
focus
patient
refractori
cr
unrespons
medic
manag
recalcitr
np
increas
express
found
patient
recalcitr
cr
exagger
respons
plu
cigarett
smoke
extract
found
cultur
epitheli
cell
patient
crssnp
excess
product
rant
reduc
baselin
express
found
cultur
epitheli
cell
patient
refractori
np
might
link
effect
local
produc
h
cytokin
type
ii
transmembran
protein
ctype
lectinlik
carbohydr
recognit
domain
transmembran
region
cytoplasm
tail
contain
immunoreceptor
tyrosinas
activ
motif
bind
specif
glucan
induc
intracellular
signal
signal
combin
enhanc
respons
trigger
receptor
defici
associ
mucocutan
candidiasi
although
dectin
receptor
regard
receptor
myeloid
cell
sun
et
al
recent
show
receptor
could
induc
airway
epitheli
cell
alternaria
speci
manner
induct
tnfa
gmcsf
although
fungal
colon
mucos
respons
fungi
receiv
much
attent
yet
studi
patient
cr
member
nodlik
receptor
protein
famili
initi
inflammatori
respons
expos
ligand
deriv
bacteri
compon
intracellularli
polymorph
lead
impair
function
increas
suscept
crohn
diseas
cd
condit
mark
excess
inflammatori
respons
normal
bacteri
flora
ligand
muramyl
dipeptid
minim
bioactiv
peptidoglycan
motif
common
bacteria
ordinarili
downregul
respons
tlr
stimul
suggest
polymorph
patient
cd
result
decreas
neg
regul
tlr
respons
patholog
increas
respons
normal
gut
flora
altern
suggest
impair
activ
pathway
might
facilit
invas
intestin
epitheli
cell
commens
pathogen
bacteria
defect
patient
ibd
express
wide
bodili
tissu
rais
question
whether
associ
ibd
cr
one
studi
found
preval
chronic
sinonas
diseas
patient
ibd
higher
preval
patient
cd
versu
ulcer
coliti
even
higher
preval
chronic
sinonas
diseas
patient
cd
obstruct
bowel
complic
vs
patient
report
cr
anoth
studi
examin
associ
found
similar
preval
cr
patient
ibd
gener
popul
although
proport
patient
cr
nasal
polyposi
higher
among
patient
ibd
studi
link
genet
polymorph
nod
pathway
gene
cr
lee
et
al
recent
discov
one
bitter
tast
receptor
activ
quorumsens
molecul
p
aeruginosa
associ
biofilm
format
bitter
tast
receptor
famili
g
proteincoupl
receptor
signal
induc
transient
intracellular
calcium
flux
stimul
ciliari
beat
frequenc
activ
receptor
induc
product
increas
ciliari
beat
frequenc
sinu
epitheli
cell
common
polymorph
variant
discov
associ
reduc
signal
product
ciliari
beat
frequenc
increas
growth
p
aeruginosa
airliquid
cultur
human
airway
epitheli
cell
effect
kill
p
aeruginosa
shown
depend
genotyp
correl
presenc
sinonas
gramneg
infect
patient
cr
suggest
mechanist
link
defici
innat
signal
increas
bacteri
infect
adapt
immun
antimicrobi
signal
mechan
signal
pathway
signatur
cytokin
h
cell
involv
host
defens
extracellular
pathogen
includ
fungi
bacteria
parasit
consid
essenti
guardian
mucos
immun
bitter
tast
receptor
activ
quorumsens
molecul
p
aeruginosa
stimul
product
stimul
mucocociliari
clearanc
direct
antimicrobi
effect
depict
intracellular
tlr
signal
pathway
adapt
iavi
report
http
tollbridgetoimmunityaspx
upper
right
inset
left
panel
sem
bacteri
biofilm
show
characterist
glycocalyx
water
channel
photograph
use
permiss
sanclement
et
al
right
panel
cslm
imag
magnif
patient
cr
stain
baclight
livedead
kit
invitrogen
molecular
probe
carlsbad
calif
demonstr
bacteri
biofilm
compris
mani
intens
fluoresc
live
bacteria
organ
cluster
larg
arrow
small
arrow
design
larger
live
dead
epitheli
cell
use
permiss
psalti
et
al
bitter
tast
receptor
depict
small
middl
inset
adapt
fenech
c
patrikainen
l
kerr
ds
grall
liu
z
laugerett
f
et
al
ga
protein
guanin
nucleotid
exchang
factor
potenti
tast
receptor
signal
front
cell
neurosci
j
allergi
clin
immunol
volum
number
extracellular
bacteria
lung
gut
intestin
epitheli
cell
stimul
product
wide
varieti
antibacteri
protein
stimul
mucin
product
inflammatori
condit
enhanc
epitheli
regener
goblet
cell
restitut
defici
mice
associ
sever
form
gramneg
enter
infect
citrobact
rodentium
increas
intestin
epitheli
damag
system
bacteri
burden
mortal
model
mediat
product
reg
famili
antimicrobi
protein
includ
regiiib
regiiic
colon
epitheli
cell
cell
includ
cell
innat
lymphoid
cell
dendrit
cell
produc
subset
helper
cell
produc
identifi
human
subject
term
h
cell
also
protect
lung
gramneg
klebsiella
pneumonia
infect
conjunct
synergist
induc
express
addit
enhanc
express
effect
airway
epitheli
cell
requir
signal
receptor
activ
signal
transduc
activ
transcript
produc
mainli
phagocyt
dendrit
cell
crucial
upstream
regul
product
although
act
synergist
addit
promot
express
gene
involv
mucos
defens
h
h
cell
like
serv
differ
role
mucos
immun
autoimmun
also
establish
role
antifung
immun
mucos
surfac
would
suggest
defect
signal
pathway
cytokin
sinu
mucosa
might
associ
difficulti
handl
fungal
infect
howev
studi
date
definit
defect
signal
identifi
patient
cr
use
genomewid
associ
studi
endam
et
al
identifi
polymorph
associ
refractori
cr
function
studi
perform
explor
relationship
reduc
express
sinu
mucos
epitheli
cell
found
patient
recalcitr
np
relationship
found
reduc
express
higher
rate
recurr
np
sinu
surgeri
long
recogn
cr
diseas
local
tissu
inflammatori
respons
might
strongli
bias
toward
h
inflamm
despit
lack
system
evid
allerg
diseas
particularli
true
patient
crswnp
also
true
lesser
degre
patient
crssnp
evid
link
colon
microorgan
maladapt
h
local
allerg
respons
patient
crswnp
schemat
fig
shown
cultur
airway
epitheli
cell
dispers
lymphocyt
np
fungi
commonli
detect
attach
mucu
sinu
tissu
patient
cr
induc
eosinophil
activ
degranul
certain
fungi
particularli
alternaria
candida
speci
shown
induc
product
well
ifng
peripher
blood
lymphocyt
patient
cr
hypothes
maladapt
respons
would
account
eosinophil
mix
h
h
mucos
immun
respons
fungal
allergen
also
elicit
modest
product
dispers
np
lymphocyt
howev
recent
studi
demonstr
consist
product
respons
alternaria
speci
patient
cr
utah
small
random
placebocontrol
trial
intranas
amphotericin
b
report
improv
radiograph
mucos
thicken
nasal
endoscopi
eosinophil
inflamm
howev
random
placebocontrol
trial
intranas
antifung
treatment
demonstr
signific
clinic
benefit
addit
antifung
treatment
alter
cytokin
chemokin
product
profil
nasal
inflammatori
cell
mucos
colon
aureu
found
patient
crswnp
compar
roughli
healthi
subject
patient
crssnp
studi
patient
massiv
polyposi
patient
found
enterotoxinproduc
aureu
nasal
mucu
adjac
polyp
shown
lymphocyt
isol
polyp
show
skew
vb
use
enrich
vb
known
respond
staphylococc
superantigen
find
later
confirm
anoth
group
ige
antibodi
direct
staphylococc
superantigen
found
np
homogen
patient
np
patient
np
coexist
asthma
final
staphylococc
enterotoxin
b
seb
found
induc
robust
product
dispers
np
lymphocyt
studi
suggest
colon
aureu
might
major
driver
local
h
inflammatori
respons
patient
crswnp
staphylococc
superantigen
seb
shown
impair
oral
toler
promot
allergi
murin
model
food
allergi
seb
also
shown
augment
allerg
inflamm
murin
model
eosinophil
cr
lead
format
nasal
polyposi
given
strong
adapt
h
chronic
inflamm
characterist
patient
crswnp
investig
undertaken
ascertain
whether
h
inflamm
modul
innat
immun
function
ramanathan
et
al
first
demonstr
cultur
primari
nasal
epitheli
cell
pnec
hc
patient
crswnp
express
surfac
respond
cpg
agonist
increas
product
found
express
pnec
patient
crswnp
reduc
compar
control
pnec
cultur
control
pnec
presenc
h
cytokin
ifng
increas
express
wherea
cultur
presenc
h
cytokin
decreas
express
group
previous
report
reduc
epitheli
express
patient
recalcitr
np
would
interest
know
whether
h
cytokin
would
induc
effect
inappropri
heighten
respons
colon
commens
organ
patient
cr
epitheli
surfac
adapt
special
mechan
cope
potenti
intrud
protect
host
infect
also
provid
benefici
effect
term
digest
gut
immun
matur
gut
respiratori
tract
mechan
also
evolv
cope
commens
gut
presum
also
oral
mucosa
nasal
epithelium
bacteri
colon
normal
suggest
cr
might
proinflammatori
respons
common
colon
organ
coagulaseneg
staphylococcu
speci
could
proinflammatori
state
cr
relat
lack
toler
seemingli
innocu
commens
organ
know
repres
excit
area
futur
investig
limit
inform
indic
patient
cr
increas
incid
rhinoviru
infect
suggest
might
exagger
respons
viral
infect
evid
persist
viral
infect
major
case
would
instruct
map
time
cours
innat
immun
respons
experiment
rhinoviru
infect
ascertain
whether
patient
cr
increas
suscept
increas
viral
burden
inappropri
innat
immun
respons
role
bacteri
infect
colon
cr
pathogenesi
well
establish
bacteria
cultur
bacteri
biofilm
present
major
patient
undergo
surgic
intervent
diseas
sinu
tissu
also
increas
bacteri
burden
convincingli
demonstr
aureu
bacteri
biofilm
organ
includ
p
aeruginosa
often
present
major
patient
cr
also
fungal
hypha
detect
mucu
extract
diseas
sinus
fungal
biofilm
detect
case
usual
associ
bacteri
biofilm
presenc
bacteri
biofilm
particularli
polymicrobi
biofilm
biofilm
contain
aureu
prognost
valu
associ
sever
sinu
diseas
preoper
wors
symptom
nasal
endoscopi
score
surgeri
mucociliari
clearanc
essenti
normal
sinu
function
activ
diseas
associ
reduct
mucociliari
clearanc
normal
mucociliari
clearanc
clearanc
infect
restor
normal
sinu
evid
primari
defect
mucociliari
clearanc
account
cr
except
distinct
clinic
syndrom
pcd
defect
local
host
innat
immun
long
suggest
pathogen
mechan
cr
account
cr
especi
system
immun
function
normal
vast
major
case
decreas
level
antimicrobi
protein
notabl
lactoferrin
found
often
sinu
secret
wherea
level
antimicrobi
protein
peptid
report
normal
multipl
innat
pattern
recognit
receptor
pathway
notabl
tlr
intracellular
nod
receptor
bitter
tast
receptor
critic
hostmicrobi
interact
sinus
primari
defect
found
pathway
account
refractori
cr
although
reduct
express
found
patient
refractori
np
downregul
epitheli
innat
immun
maladapt
h
tissu
inflamm
demonstr
patient
recalcitr
crswnp
vitro
studi
shown
decreas
express
cultur
epitheli
cell
nearli
also
reduc
express
spa
colon
fungi
might
play
role
maladapt
h
respons
therebi
promot
tissu
eosinophilia
colon
enterotoxinproduc
aureu
driver
local
h
respons
patient
crswnp
induc
local
expans
lymphocyt
product
enterotoxinspecif
ige
antibodi
date
effect
mean
restor
hostmicrobi
balanc
mitig
diseas
patient
cr
remain
elus
studi
effect
medic
treatment
alon
erad
bacteri
infect
bacteri
biofilm
patient
cr
clinic
trial
antifung
rins
gener
unsuccess
surgic
remov
diseas
sinu
tissu
restor
sinu
ventil
use
culturedirect
antibiot
remain
best
approach
treatment
hope
elucid
genet
underpin
cr
hostmicrobi
interact
present
provid
greater
insight
diseas
pathogenesi
effect
treatment
one
studi
use
sensit
molecular
techniqu
pcr
found
evid
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
mucos
sampl
patient
cr
recent
studi
use
pyrosequenc
potenti
overcom
issu
detect
noncultur
bacteria
mucos
sampl
patient
cr
detect
mycoplasma
ureaplasma
chlamydia
speci
found
legionella
mycobacterium
nocardia
speci
rare
case
tichenor
et
al
identifi
patient
cr
refractori
symptom
posit
cultur
atyp
mycobacteria
period
mycobacterium
avium
molecular
fingerprint
clonal
relat
patient
isol
also
identifi
plumb
household
sampl
suggest
least
case
indoor
plumb
sinu
irrig
might
respons
infect
solyar
et
al
report
seri
patient
refractori
cr
posit
mycobacteri
cultur
period
frequent
isol
mycobacterium
abscessu
mycobacterium
aviumintracellular
complex
mycobacterium
chelona
report
outpatientacquir
inpatientacquir
cultur
posit
atyp
mycobacteria
evid
improv
cr
note
treatment
antimycobacteri
antibiot
studi
suggest
atyp
mycobacteri
infect
rare
patient
cr
sought
patient
refractori
cr
see
tabl
summari
studi
bacteri
fungal
biofilm
patient
cr
sem
tem
advantag
high
magnif
techniqu
provid
ultrastructur
confirm
biofilm
presenc
technic
artifact
aris
sampl
dehydr
surfac
distort
disadvantag
sem
includ
small
sampl
size
potenti
introduc
sampl
artifact
cslm
advantag
specimen
imag
without
fixat
dehydr
specif
bacteria
fungi
stain
fluoresc
marker
fish
assay
use
either
univers
bacteri
probe
speciesspecif
primer
base
uniqu
sequenc
ribosom
rna
gene
livedead
baclight
bacteri
viabil
kit
invitrogen
carlsbad
calif
use
nucleic
acid
stain
greenfluoresc
syto
stain
label
live
dead
bacteria
redfluoresc
propidium
iodid
penetr
bacteria
cell
damag
membran
cslm
use
confirm
presenc
biofilm
mucos
surfac
bacteriaspecif
probe
use
direct
comparison
techniqu
sheep
model
rhinosinus
conclud
cslm
object
document
biofilm
presenc
sem
tem
inher
flaw
sampl
error
subject
involv
sem
tem
anoth
studi
determin
baclight
method
specif
cslmfish
biofilm
detect
sinu
tissu
hochstim
et
al
report
bacteri
biofilm
detect
use
routin
hematoxylineosin
stain
good
agreement
fishcslm
control
standard
howev
techniqu
suspect
relianc
identif
small
basophil
bacteri
cluster
epitheli
surfac
concern
whether
techniqu
sem
tem
suffici
rigor
defin
biofilm
provid
ultrastructur
confirm
presenc
biofilm
calgari
biofilm
assay
vitro
test
use
assess
abil
bacteri
isol
form
biofilm
bacteria
cultur
plate
round
peg
posit
plate
semiquantit
analysi
use
uptak
crystal
violet
biofilm
develop
livedead
baclight
bacteri
viabil
kit
see
also
use
assess
biofilm
format
vitro
chamber
slide
princ
et
al
use
calgari
biofilm
detect
assay
examin
patient
cr
mucopurul
found
patient
biofilmform
capac
polymicrobi
cultur
p
aeruginosa
andor
aureu
compris
sampl
postsurg
case
higher
preval
biofilmform
capac
surgeryna
patient
vs
iedap
dlactyllalagglumesodapgli
heptanolylgglumesodapala
gmtripeptid
adapt
bal
heimstra
ooi
et
al
roeder
et
al
dna
contain
unmethyl
cpg
dinucleotid
